Acute viral hepatitis increases liver stiffness values measured by transient elastography U Arena, F Vizzutti, G Corti, S Ambu, C Stasi, S Bresci, S Moscarella, ... Hepatology 47 (2), 380-384, 2008 | 922 | 2008 |
Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis F Vizzutti, U Arena, RG Romanelli, L Rega, M Foschi, S Colagrande, ... Hepatology 45 (5), 1290-1297, 2007 | 898 | 2007 |
Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis A Berzigotti, S Seijo, U Arena, JG Abraldes, F Vizzutti, JC García–Pagán, ... Gastroenterology 144 (1), 102-111. e1, 2013 | 617 | 2013 |
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis V Nobili, F Vizzutti, U Arena, JG Abraldes, F Marra, A Pietrobattista, ... Hepatology 48 (2), 442-448, 2008 | 478 | 2008 |
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells S Aleffi, I Petrai, C Bertolani, M Parola, S Colombatto, E Novo, F Vizzutti, ... Hepatology 42 (6), 1339-1348, 2005 | 472 | 2005 |
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C U Arena, F Vizzutti, JG Abraldes, G Corti, C Stasi, S Moscarella, S Milani, ... Gut 57 (9), 1288-1293, 2008 | 358 | 2008 |
Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice M Fernandez, F Vizzutti, JC Garcia-Pagan, J Rodes, J Bosch Gastroenterology 126 (3), 886-894, 2004 | 347 | 2004 |
Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease V Nobili, J Parkes, G Bottazzo, M Marcellini, R Cross, D Newman, ... Gastroenterology 136 (1), 160-167, 2009 | 318 | 2009 |
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells M Trappoliere, A Caligiuri, M Schmid, C Bertolani, P Failli, F Vizzutti, ... Journal of hepatology 50 (6), 1102-1111, 2009 | 316 | 2009 |
Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial Y Panahi, N Khalili, E Sahebi, S Namazi, LE Simental-Mendía, M Majeed, ... Drug research 68 (07), 403-409, 2018 | 237 | 2018 |
Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography M Pinzani, F Vizzutti, U Arena, F Marra Nature Clinical Practice Gastroenterology & Hepatology 5 (2), 95-106, 2008 | 237 | 2008 |
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial RG Romanelli, G La Villa, G Barletta, F Vizzutti, F Lanini, U Arena, ... World journal of gastroenterology: WJG 12 (9), 1403, 2006 | 181 | 2006 |
Adenosine monophosphate–activated protein kinase modulates the activated phenotype of hepatic stellate cells A Caligiuri, C Bertolani, CT Guerra, S Aleffi, S Galastri, M Trappoliere, ... Hepatology 47 (2), 668-676, 2008 | 166 | 2008 |
Safety and efficacy of rituximab in patients with hepatitis C virus–related mixed cryoglobulinemia and severe liver disease A Petrarca, L Rigacci, P Caini, S Colagrande, P Romagnoli, F Vizzutti, ... Blood, The Journal of the American Society of Hematology 116 (3), 335-342, 2010 | 143 | 2010 |
Consensus conference on TIPS management: techniques, indications, contraindications S Fagiuoli, R Bruno, WD Venon, F Schepis, F Vizzutti, P Toniutto, ... Digestive and Liver Disease 49 (2), 121-137, 2017 | 142 | 2017 |
Curcumin limits the fibrogenic evolution of experimental steatohepatitis F Vizzutti, A Provenzano, S Galastri, S Milani, W Delogu, E Novo, ... Laboratory Investigation 90 (1), 104-115, 2010 | 126 | 2010 |
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice E Zamara, S Galastri, S Aleffi, I Petrai, M Aragno, R Mastrocola, E Novo, ... Journal of hepatology 46 (2), 230-238, 2007 | 121 | 2007 |
Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis F Schepis, F Vizzutti, G Garcia-Tsao, G Marzocchi, L Rega, N De Maria, ... Clinical Gastroenterology and Hepatology 16 (7), 1153-1162. e7, 2018 | 116 | 2018 |
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis G La Villa, G Barletta, P Pantaleo, R Del Bene, F Vizzutti, S Vecchiarino, ... Hepatology 34 (1), 19-27, 2001 | 114 | 2001 |
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes F Vizzutti, F Schepis, U Arena, F Fanelli, S Gitto, S Aspite, L Turco, ... Internal and emergency medicine 15, 37-48, 2020 | 88 | 2020 |